Based on the latest survey of more than 25,000 companies, the German Chamber of Industry and Trade (DIHK) reported that business leaders’ outlook for Germany, Europe’s largest economy, remained resilient amid recent economic unrest in Greece and Spain.
Some 42% of companies viewed the current conditions of their businesses as “good,” while 48% felt “satisfactory,” and 10% believed “poor,” the DIHK said.
Legislation enabling the largest ever reorganisation of the National Health Service (NHS) is imminent, after the government won a parliamentary vote on its Health and Social Care Bill by a majority of 54 votes.
Through a series of measures, including the abolition of Primary Care Trusts and the establishment of “clinical commissioning groups,” the bill effectively ends free and comprehensive health care, handing huge swathes of the NHS over to the private sector.
Hospitals will be able to use fully 49% of their hospital beds and theatre time to generate private income. Commissioning groups will see doctors and other healthcare professionals take control of their budgets and be able to buy in services from other providers.
With healthcare spending in China rising 20% annually and estimated to reach $705 billion by 2015, the market is ripe for foreign investors looking to cash in on China’s healthcare boom. Health services — such as in hospitals and insurance — and medical devices are booming markets in China, but foreign investors need to study the market, understand local conditions and place their bets very carefully, according to a panel of experts from China and the U.S.
Decree on Improvement of Public Health Policy: Russian president Vladimir Putin has signed a decree “On the improvement of public health policy”. The decree has wide implications for healthcare policy, as well as important implications for the pharmaceutical sector. The newly signed decree “On the improvement of public health policy” puts a strong focus on achieving reductions in mortality across a range of diseases, and also crucially gives expectations of the increased volume of production for domestic manufacturers.
With the various areas the decree covers, as well as through giving specific targets and deadlines for the development and implementation of the policies, changes in existing laws and new regulations in healthcare provision can be expected in the near future for Russia.